Antimicrobial resistance of Escherichia coli strains causing neonatal sepsis between 1998 and 2008

Chemotherapy

Volumn 58, Issue 2, 2012, Pages 123-128

  Guiral, Elisabet ^a   Bosch, Jordi ^a,b   Vila, Jordi ^a,b   Soto, Sara M ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antimicrobial resistance mechanisms; Escherichia coli; Neonatal sepsis

Indexed keywords

GENTAMICIN; PIPERACILLIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CLINICAL EVALUATION; CONTROLLED STUDY; EARLY ONSET NEONATAL SEPSIS; ESCHERICHIA COLI; HOSPITAL; HOSPITAL INFECTION; LATE ONSET NEONATAL SEPSIS; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENTAMICINS; HUMANS; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PIPERACILLIN; SEPSIS; TOBRAMYCIN;

EID: 84860868944     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000337062     Document Type: Article

References (27)

1. Placzek MM, Whitelaw A: Early and late neonatal septicaemia. Arch Dis Child 1983; 58: 728-731.
2. Soto SM, Bosch J, Jimenez de Anta MT, Vila J: Comparative study of virulence traits of Escherichia coli clinical isolates causing early and late neonatal sepsis. J Clin Microbiol 2008; 46: 1123-1125.
3. Stoll BJ, Hansen N, Fanaroff AA, et al: Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002; 347: 240-247.
4. Towers CV, Carr MH, Padilla G, Asrat T: Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998; 179: 879-993.
5. Friedman S, Shah V, Ohlsson A, Matlow AG: Neonatal Escherichia coli infections: concerns regarding resistance to current therapy. Acta Paediatr 2000; 89: 686-689.
6. Amstey MS: Group B streptococcal prophylaxis. Am J Obstet Gynecol 1994; 171: 1675.
7. Klein JO: Antimicrobial therapy issues facing pediatricians. Pediatr Infect Dis J 1995; 14: 415-419.
8. Wiese G: Treatment of neonatal sepsis with ceftriaxone/gentamicin and with azlocillin/gentamicin: a clinical comparison of efficacy and tolerability. Chemotherapy 1988; 34: 158-163.
9. Moore MR, Schrag SJ, Schuchat A: Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3: 201-213.
10. Vergnano S, Menson E, Kennea N, et al: Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011; 96:F9-F14.
11. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. 16th informational supplement, M100-S18. Wayne, CLSI, 2008.
12. Perreten V, Boerlin P: A new sulfonamide resistance gene ( sul 3) in Escherichia coli is widespread in the pig population of Switzerland. Antimicrob Agents Chemother 2003; 47: 1169-1172.
13. Guerra B, Junker E, Miko A, Helmuth R, Mendoza MC: Characterization and localization of drug resistance determinants in multidrug-resistant, integron-carrying Salmonella enterica serotype Typhimurium strains. Microb Drug Resist 2004; 10: 83-91.
14. Akinbowale OL, Peng H, Barton MD: Diversity of tetracycline resistance genes in bacteria from aquaculture sources in Australia. J Appl Microbiol 2007; 103: 2016-2025.
15. Ozgumus OB, Celik-Sevim E, Alpay-Karaoglu S, Sandalli C, Sevim A: Molecular characterization of antibiotic resistant Escherichia coli strains isolated from tap and spring waters in a coastal region in Turkey. J Microbiol 2007; 45: 379-387.
16. Sanfilippo CM, Heske CK, Haas W, Morris TW: Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin. Chemotherapy 2011; 57: 363-371.
17. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG: Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121: 689-696.
18. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992; 90: 775-778.
19. Centers for Disease Control and Prevention: Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996; 45: 1-24.
20. Schrag SJ, Stoll BJ: Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 2006; 25: 939-940.
21. Joseph TA, Pyati SP, Jacobs N: Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998; 152: 35-40.
22. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG: Neonatal sepsis and death caused by resistant Escherichia coli : possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 1999; 180: 1345-1348.
23. Kuhn P, Dheu C, Bolender C, et al: Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics. Paediatr Perinat Epidemiol 2010; 24: 479-487.
24. Thaver D, Ali SA, Zaidi AK: Antimicrobial resistance among neonatal pathogens in developing countries. Pediatr Infect Dis J 2009; 28:S19-21.
25. Seo MR, Park YS, Pai H: Characteristics of plasmid-mediated quinolone resistance genes in extended-spectrum cephalosporin-resistant isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Chemotherapy 2010; 56: 46-53.
26. Karami N, Nowrouzian F, Adlerberth I, Wold AE: Tetracycline resistance in Escherichia coli and persistance in the infantile colonic microbiota. Antimicrob Agents Chemother 2006; 50: 156-161.
27. Karami N, Hannoun C, Adlerberth I, Wold AE: Colonization dynamics of ampicillinresistant Escherichia coli in the infantile colonic microbiota. J Antimicrob Chemother 2008; 62: 703-708.